News

Kountable and Proof Market Partner to Solve Digital ID and Deliver Rapid Diagnostic Testing for Women Across the Global South

Kountable and Proof Market announce a strategic alliance to source and deliver Diabetes, COVID-19, and other rapid diagnostic test kits to women across Low and Middle Income Countries. The alliance will empower one billion women in developing countries including Africa, India, and the Middle East with access to the highest quality rapid diagnostic test kits they need, at the price, volume, and…

SimpleHealth Waives Consultation Fee for Unemployed Women Needing Access to Birth Control

SimpleHealth, an online reproductive health provider, is is waiving the $20 consultation fee for all unemployed women seeking access to birth control through the end of January 2021. The announcement comes after reports indicated that of the 140,000 jobs lost in the last month, nearly all of them were held by women – the overwhelming majority of which were held by women of color. SimpleHealth can ship…

Report: 2020 Market Insights Report – Chasing a New Equilibrium (Rock Health)

Rock Health recently released a new report reflecting on the past year in digital health. The report covers investor & investment activity, consumer behavior change, enterprise buyer behavior, exit & public market activity and an outlook. 2020’s stress test to our healthcare system created what felt like a fast forward button for digital health, with unprecedented growth in funding, adoption, policymaking, and…

SynDexRx: New Drug Tackles the Relationship Between Obesity and Breast Cancer

While cancer therapies are getting more personalized (and expensive), patient outcomes don’t seem to improve along the same trajectory and SynDevRx believes to know why that is. According to the company’s research the answer lies in the way that obesity, diabetes, and other forms of metabolic dysfunction accelerate tumor growth and metastasis, making at least 13 common types of cancer much more…

Women’s Health Startup Tia Launches Virtual Care at Their Second Location in Los Angeles

Tia recently announced the opening of its second location in Los Angeles. While in-person care will officially start in March 2021, virtual care is available as of now. Tia is known for championing the concept of “Whole Person Health” and aims to recreate a healthcare system that was designed for specialties, body parts, and treating sickness. The company announced the close of…

Launched: Mae, a Maternal Health Tech Platform for Black Expectant Mothers

Last week Mae, a maternal health tech startup focused on providing critical resources to Black expectant mothers in the U.S. announced their soft-launch. ´The platform features a free birth planning tool that anyone can access, and free 15 minute consults with doulas for interested expectant mothers. The platform’s founder Maya Hardigan explains: “Mae is a digital health platform that elevates the standard of care for Black…

Pregna Launches CryoPop, a Carbon Dioxide (CO2) Based Innovative Cryotherapy Device to Fight Cervical Cancer

Pregna has recently announced the launch of its cryotherapy device CryoPop. The product was developed by Jhpiego with an objective of making treatment of cervical pre-cancerous lesions accessible to all. Pregna is the exclusive global commercialising partner for the device. “Cervical cancer is one of the most common and fatal forms of cancer in women worldwide, with about 85% of these deaths occurring in low and…

Runway Growth Capital Announces a Senior Secured Term Loan of $50M to Gynesonics for Their Intrauterine Fibroid Ablation System

Runway Growth Capital, a provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, announced today the closing of a senior secured term loan of $50 million to Gynesonics, a healthcare company focused on advancing women’s health by developing minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications. Gynesonics has developed and has received FDA clearance for…